EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice

Fanglin Qin, Yiming Yan, Ningxi Yang, Yarong Hao

Experimental and Clinical Endocrinology & Diabetes · 01.08.2024 · 132 (08) · 420-430

DOI: 10.1055/a-2298-4593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.08.2024. Verfasst von Fanglin Qin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Renmin Hospital of Wuhan University, 99 Zhang Zhidong Road, Wuchang District, Wuhan, Hubei Province 430060, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycosides, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hubei Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cognitive dysfunction is an important comorbidity of diabetes. Insulin resistance may play a critical role in diabetes-related cognitive impairment. Echinacoside (ECH), a natural phenylethanoid glycoside, is the active component of anti-diabetes prescriptions in traditional Chinese medicine. Its effect on modulating insulin resistance has been confirmed but modulating neurodegenerative disease remains unclear.

Methods

Db/db mice, a spontaneous type 2 diabetes mode, were intragastrically administered ECH by 300 mg/kg or an equivalent volume of saline. Weight, blood glucose, and insulin resistance index were measured. Morris water maze test was performed to observe the compound effects on cognition. Hippocampal lesions were observed by histochemical analysis.

Results

In db/db mice, ECH alleviated diabetes symptoms, memory loss, and hippocampal neuronal damage. Next, the expression of CD44 and phosphorylated tau was upregulated in diabetic mice. In addition, the insulin receptor substrate-1/phosphatidylinositol 3-kinase /protein kinase B signaling pathway was dysregulated in diabetic mice. All these dysregulations could be reversed by ECH.

Discussion

This study provides theoretical support and experimental evidence for the future application of ECH in diabetic cognition dysfunction treatment, promoting the development of traditional medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2GlycosidesCognitive DysfunctionAnimalsMiceMaleDiabetes Mellitus, ExperimentalHippocampusInsulin Resistance

Substanzen

echinacosideGlycosides

Autor:innen und Institutionen

  • Department of Geriatrics, Renmin Hospital of Wuhan University, 99 Zhang Zhidong Road, Wuchang District, Wuhan, Hubei Province 430060, China.

Förderung

  • Hubei Natural Science Foundation of China

Zitieren

APA

Qin, F., Yan, Y., Yang, N., & Hao, Y. (2024). Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice. Experimental and Clinical Endocrinology & Diabetes, 132(08), 420-430. https://doi.org/10.1055/a-2298-4593

Vancouver

Qin F, Yan Y, Yang N, Hao Y. Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice. Experimental and Clinical Endocrinology & Diabetes. 2024;132(08):420-430. doi:10.1055/a-2298-4593

BibTeX
@article{Qin2024,
  author = {Qin, Fanglin and Yan, Yiming and Yang, Ningxi and Hao, Yarong},
  title = {Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2024},
  volume = {132},
  number = {08},
  pages = {420--430},
  doi = {10.1055/a-2298-4593}
}
Kostenlos starten →